Wang, Haocheng
Fei, Chunming
Cao, Youhong
Cui, Guiping
Zhao, Junning
Yang, Weixuan
Xi, Meijuan
Wang, Xiujuan
Gao, Jiahuan
Zhang, Zhenyu
Article History
Received: 3 February 2026
Accepted: 16 April 2026
First Online: 20 April 2026
Declarations
:
: This study is a prospective, multicenter, open-label, randomized controlled trial. It was approved by the Medical Ethics Committee of Nanjing First Hospital Affiliated to Nanjing Medical University (Approval No. KY20240123-21). The trial was conducted in accordance with the Declaration of Helsinki, using commercially available and widely adopted medications. All participants were fully informed of potential risks and provided written informed consent.
: Not applicable.
: The authors declare no competing interests.